Article
Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus
2024-02-02
Abstract excerpt
<h4>Introduction: </h4> Advanced glycation end-products (AGEs) may play a relevant role as inducers in the chronic inflammatory pathway present in immune-mediated diseases, such as systemic lupus erythematosus (SLE). AGEs concentrations have been associated, with discrepant results to date, with some parameters such as disease activity or accrual damage, suggesting their potential usefulness as biomarkers of the d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8841157-bd99-5b15-9758-2411b9b719d9
- DOI
- 10.20944/preprints202402.0079.v1
